You are here: Industry Insights > Moderna

News List

Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of Moderna’s COVID-19 Vaccine or Updated Booster Candidate in 2022 FirstWordPharma
December 28, 2021
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a revised supply agreement with the government of South Korea for 20 million doses...
Moderna says booster dose of its COVID-19 vaccine appears protective against Omicron expresspharma
December 21, 2021
The company still plans to develop a vaccine specifically to protect against Omicron, which it hopes to advance into clinical trials early next year
CDC Panel Advises That Other Vaccines Be Preferred Over J&J Shot Drugs
December 17, 2021
Following continued reports of a rare but life-threatening clotting condition linked to the Johnson & Johnson coronavirus vaccine, a federal advisory panel on Thursday recommended that the Pfizer/BioNTech...
Moderna Spikevax Receives Marketing Authorization in Korea contractpharma
December 16, 2021
The Moderna COVID-19 vaccine manufactured at Samsung Biologics’ local production facilities can be distributed in Korea and exported to other countries.
mRNA-1010 quadrivalent flu vaccine shows promise in Phase I study EuropeanPharmaceuticalReview
December 15, 2021
Moderna’s quadrivalent flu vaccine mRNA-1010 boosted titres against all four strains 29 days after vaccination in young and older adults.
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea prnasia
December 14, 2021
Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced today that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing authorization...
Moderna amends Covid-19 vaccine supply deal with Gavi Pharmaceutical-Technology
December 14, 2021
Moderna has amended an existing contract with Gavi, the Vaccine Alliance, to expedite the supply of 20 million doses of its Covid-19 vaccine to COVAX by the end of this year.
UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response PharmaTimes
December 08, 2021
Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.
UK study finds mRNA COVID-19 vaccines provide biggest booster impact expresspharma
December 03, 2021
The study found that six out of the seven boosters examined enhanced immunity after initial vaccination with Pfizer-BioNTech's vaccine, while all seven increased immunity when given after two doses of AstraZeneca's vaccine.
Moderna Edges Pfizer in Study of Five Covid Vaccines FirstWordPharma
November 26, 2021
According to the paper published on the website of the Clinical Microbiology and Infection journal, Moderna's COVID-19 vaccine edged Pfizer/BioNTech's jab in effectiveness...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page